Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa

Published:2017-12-18 Issue:4 Volume:73 Page:942-952
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Monogue Marguerite L¹,Nicolau David P¹²

Affiliation:

1. Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA

2. Division of Infectious Diseases, Hartford Hospital, Hartford, CT, USA

Funder

Merck

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/4/942/24269527/dkx483.pdf

Reference47 articles.

1. A brief history of the antibiotic era: lessons learned and challenges for the future;Aminov;Front Microbiol,2010

2. Mechanisms of antimicrobial resistance in bacteria;Tenover;Am J Med,2006

3. Hospital-acquired infections due to Gram-negative bacteria;Peleg;N Engl J Med,2011

4. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010;Sievert;Infect Control Hosp Epidemiol,2013

5. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009;Zilberberg;J Hosp Med,2013

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa : insights from the hollow-fiber infection model;Infectious Diseases;2024-08-30

2. In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa;Pharmaceuticals;2024-06-12

3. Development of rabbit models of ventilator-associated bacterial pneumonia produced by carbapenem-resistant Pseudomonas aeruginosa;Antimicrobial Agents and Chemotherapy;2024-04-30

4. Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections;Antibiotics;2023-11-23

5. Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa;Pharmaceuticals;2023-08-30